P-125 Adalimumab Serum Concentrations or Anti-Drug Antibodies Do Not Influence Fatigue in Patients w...
P-125 Adalimumab Serum Concentrations or Anti-Drug Antibodies Do Not Influence Fatigue in Patients with Crohn's Disease
About this item
Full title
Author / Creator
Publisher
Oxford, UK: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Fatigue is a common phenomenon in patients with inflammatory bowel diseases (IBD). Biological treatment alleviates fatigue in a number of diseases, but it is unclear whether different serum concentrations of the drug or development of anti-drug antibodies influence fatigue.MethodsIn a cohort of adult patients with Crohn's disease, who had received...
Alternative Titles
Full title
P-125 Adalimumab Serum Concentrations or Anti-Drug Antibodies Do Not Influence Fatigue in Patients with Crohn's Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3169869115
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3169869115
Other Identifiers
ISSN
1078-0998
E-ISSN
1536-4844
DOI
10.1097/01.MIB.0000512644.54196.10
